Jan van Lunzen
Affiliation: University Medical Center Hamburg-Eppendorf
- Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trialJan van Lunzen
Infectious Diseases Unit, University Medical Centre Hamburg Eppendorf, Martinistrasse 52, Hamburg, Germany
Lancet Infect Dis 12:111-8. 2012..SPRING-1 is an ongoing study designed to select a dose for phase 3 assessment. We present data from preplanned primary and interim analyses...
- Gene therapy strategies: can we eradicate HIV?Jan van Lunzen
Infectious Diseases Unit, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
Curr HIV/AIDS Rep 8:78-84. 2011..Indeed the intriguing finding that HIV seems to be eradicated in an individual case study after stem cell transplantation with a mutant coreceptor (CCR5 delta 32 deletion) underlines the proof of the concept...
- Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCGPhilip Hartjen
Infectious Diseases Unit, I, Department of Internal Medicine, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20251 Hamburg, Germany
AIDS Res Ther 9:2. 2012..However, the reasons for the variability in the efficacy of the abrogation of semen-mediated enhancement of HIV-1 infectivity and EGCG efficacy have to be elucidated before therapeutic trials can be conducted...
- Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfectionJulian Schulze zur Wiesch
Department of Medicin, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Clin Infect Dis 49:466-72. 2009..We present detailed clinical and immunological analysis of 3 individuals after concomitant infection with acute HCV and primary HIV...
- Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustionIlona Tóth
1 Section Infectious Diseases, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
J Leukoc Biol 94:551-61. 2013..These data indicate that down-regulation of CD73 on CD8(+) T cells correlates with immune activation and leads to functional deficits in HIV infection. ..
- Improved outcome with rituximab in patients with HIV-associated multicentric Castleman diseaseChristian Hoffmann
Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany
Blood 118:3499-503. 2011....
- Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasisChristian Hoffmann
University Medical Centre Hamburg Eppendorf, Hamburg, Germany
Br J Haematol 136:641-8. 2007..The clearance kinetics of the transfused cells from peripheral blood indicates a very rapid regulation of T-cell homeostasis in HIV infection...
- Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphomaAlexander Zoufaly
Infectious Diseases Unit, Department of Medicine, University Medical Center Hamburg Eppendorf, Germany
J Infect Dis 200:79-87. 2009..We assessed the predictive role of cumulative HIV viremia and other risk factors in the development of AIDS-related non-Hodgkin lymphoma...
- Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive diseaseJulian Schulze zur Wiesch
Infectious Disease Unit, Department of Medicine, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
J Virol 85:1287-97. 2011..The data presented here reconcile the seemingly contradictory results of previous studies looking at Tregs in HIV and highlight the complexity of Treg-mediated immunoregulation during human viral infections...
- Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patientsChristoph Wyen
Department of Internal Medicine, University of Cologne, Koln, Germany
J Antimicrob Chemother 61:914-8. 2008..The aim of this study was to investigate the frequency of CYP2B6 polymorphisms (according to ethnicity) and the influence of heterozygosity and homozygosity on plasma concentrations of efavirenz and nevirapine...
- Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohortMatthias Stoll
Infectious Diseases Unit, Medical University, Hanover, Germany
PLoS ONE 6:e23946. 2011..The second aim was to develop potential cost saving strategies by modelling different treatment scenarios...
- Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virusJan van Lunzen
Infectious Diseases Unit, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Mol Ther 15:1024-33. 2007..In conclusion, the transfer of gene-modified cells was safe, led to sustained levels of gene marking, and may improve immune competence in HIV-infected patients with advanced disease and multidrug-resistant virus...
- Stereoselective synthesis of D- and L-carbocyclic nucleosides by enzymatically catalyzed kinetic resolutionMiriam Mahler
Organic Chemistry, Department of Chemistry, Faculty of Sciences, University of Hamburg, Hamburg, Germany
Chemistry 18:11046-62. 2012..However, against the wild-type virus strain NL4/3, d4T was found to be more-active than D-carba-dT...
- How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infectionJan van Lunzen
University Medical Centre Hamburg Eppendorf, Heinrich Pette Institute for Experimental Virology and Immunology, Hamburg, Germany
Eur J Med Res 12:435-40. 2007....
- Virological rebound and its consequences during treatment interruptionJan van Lunzen
aUniversity Medical Center Hamburg Eppendorf and Heinrich Pette Institute for Experimental Virology and Immunology, Germany bInstitute for Interdisciplinary Medicine, Hamburg, Germany
Curr Opin HIV AIDS 2:1-5. 2007..SUMMARY: Treatment interruptions cannot be recommended in HIV-infected patients outside clinical trials, especially when profound immune deficiency is found to be preexisting...
- Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)Hans Jurgen Stellbrink
Department of Medicine, Eppendorf University, Hamburg, Germany
AIDS 16:1479-87. 2002..The effect of interleukin-2 (IL-2) in combination with antiretroviral therapy on HIV-1 replication and reservoirs was investigated...